Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f35b0b9b1f30478718a73d516338c659 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
filingDate |
2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32a8ba99de1d186e1f6da0ee3cc473f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7361dd6854fbc90cca99635fbd4159b7 |
publicationDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010129927-A1 |
titleOfInvention |
Peptides for Use in Diagnosing the Presence of Ruptured Atherosclerotic Lesions in a Individual |
abstract |
The present invention relates to peptides that are able to interact with ruptured atherosclerotic plaque-associated antibodies, which peptides comprise an immunoreactive part of one of the amino acid sequences according to SEQ ID NOS: 1-25. The invention further relates to a diagnostic reagent comprising the peptides, to the use of the method and to a method and test kit for the diagnosis of a sample from an individual for the presence therein of antibodies that are indicative of the presence of ruptured atherosclerotic plaques in the individual. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8672857-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011071583-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143954-A1 |
priorityDate |
2006-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |